Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
50
Number of overlapping holdings
14.5%
% of FHLC's 369 holdings also in FMED
86.2%
% of FMED's 65 holdings also in FHLC
Overlap by Weight
Sector Drift (FHLC minus FMED)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FHLC |
Weight in FMED |
Overlap | |
|---|---|---|---|---|
 |
UNITEDHEALTH GROUP INC | 8.3% | 4.7% | 4.7% |
|
DANAHER CORP | 3.0% | 3.9% | 3.0% |
|
INTUITIVE SURGICAL INC | 2.5% | 3.8% | 2.5% |
|
ELI LILLY & CO | 10.2% | 2.3% | 2.3% |
|
MERCK & CO. INC. | 5.0% | 2.3% | 2.3% |
Position Highlights (Non-Overlapping Exposures)
FHLC Overweight Relative to FMED
|
ELI LILLY & CO | 7.9% |
|
JOHNSON & JOHNSON | 6.1% |
|
ABBVIE INC | 5.2% |
|
UNITEDHEALTH GROUP INC | 3.6% |
|
ABBOTT LABORATORIES | 2.9% |
|
AMGEN INC | 2.8% |
|
PFIZER INC | 2.7% |
|
MERCK & CO. INC. | 2.7% |
|
ELEVANCE HEALTH INC | 1.9% |
 |
MEDTRONIC PLC | 1.6% |
FHLC Underweight Relative to FMED
|
ALNYLAM PHARMACEUTICALS INC | -3.9% |
|
BOSTON SCIENTIFIC CORP | -3.8% |
|
INSULET CORP | -3.2% |
|
LEGEND BIOTECH CORPORATION SPONSORED | -3.0% |
 |
ARGENX SE ADR | -2.9% |
|
EXACT SCIENCES CORP | -2.4% |
|
UCB SA | -2.3% |
|
PENUMBRA, INC. | -2.0% |
|
REGENERON PHARMACEUTICALS | -2.0% |
|
LIFESTANCE HEALTH GROUP, INC. | -2.0% |